» Articles » PMID: 34484215

Group 2 Innate Lymphoid Cells Exhibit Tissue-Specific Dynamic Behaviour During Type 2 Immune Responses

Overview
Journal Front Immunol
Date 2021 Sep 6
PMID 34484215
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Group 2 innate lymphoid cells (ILC2s) are early effectors of mucosal type 2 immunity, producing cytokines such as interleukin (IL)-13 to mediate responses to helminth infection and allergen-induced inflammation. ILC2s are also present in lymph nodes (LNs) and can express molecules required for antigen presentation, but to date there are limited data on their dynamic behaviour. We used a CD2/IL-13 dual fluorescent reporter mouse for imaging of ILC2s and Th2 T cells in real time following a type 2 priming helminth infection or egg injection. After helminth challenge, we found that ILC2s were the main source of IL-13 in lymphoid organs (Peyer's patches and peripheral LNs), and were located in T cell areas. Intravital imaging demonstrated an increase in IL-13 ILC2 size and movement following helminth infection, but reduced duration of interactions with T cells compared with those in homeostasis. In contrast, in the intestinal mucosa, we observed an increase in ILC2-T cell interactions post-infection, including some of prolonged duration, as well as increased IL-13 ILC2 movement. These data suggest that ILC2 activation enhances cell motility, with the potential to increase the area of distribution of cytokines to optimise the early generation of type 2 responses. The prolonged ILC2 interactions with T cells within the intestinal mucosa are consistent with the conclusion that contact-based T cell activation may occur within inflamed tissues rather than lymphoid organs. Our findings have important implications for our understanding of the biology of ILC2s and the way in which these cells facilitate adaptive immune responses.

Citing Articles

Elevated circulating group-2 innate lymphoid cells expressing activation markers and correlated tryptase AB1 levels in active ascariasis.

Lopez J, Zakzuk J, Satitsuksanoa P, Lozano A, Buergi L, Heider A Front Immunol. 2024; 15:1459961.

PMID: 39524451 PMC: 11549673. DOI: 10.3389/fimmu.2024.1459961.


Investigating the impact of antibiotic-induced dysbiosis on protection from colitis by mouse colonic innate lymphoid cells.

Uddin M, Thompson B, Leslie J, Fishman C, Sol-Church K, Kumar P mBio. 2024; 15(3):e0333823.

PMID: 38376154 PMC: 11209775. DOI: 10.1128/mbio.03338-23.


Mechanistic Insights into Eosinophilic Esophagitis: Therapies Targeting Pathophysiological Mechanisms.

Massironi S, Mulinacci G, Gallo C, Elvevi A, Danese S, Invernizzi P Cells. 2023; 12(20).

PMID: 37887317 PMC: 10605530. DOI: 10.3390/cells12202473.


Intravital imaging of immune responses in intestinal inflammation.

Honda M, Kadohisa M, Yoshii D, Komohara Y, Hibi T Inflamm Regen. 2023; 43(1):9.

PMID: 36737792 PMC: 9896837. DOI: 10.1186/s41232-023-00262-w.


Crosstalk between epithelium, myeloid and innate lymphoid cells during gut homeostasis and disease.

Ghilas S, OKeefe R, Mielke L, Raghu D, Buchert M, Ernst M Front Immunol. 2022; 13:944982.

PMID: 36189323 PMC: 9524271. DOI: 10.3389/fimmu.2022.944982.


References
1.
Neill D, Wong S, Bellosi A, Flynn R, Daly M, Langford T . Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature. 2010; 464(7293):1367-70. PMC: 2862165. DOI: 10.1038/nature08900. View

2.
Hung L, Lewkowich I, Dawson L, Downey J, Yang Y, Smith D . IL-33 drives biphasic IL-13 production for noncanonical Type 2 immunity against hookworms. Proc Natl Acad Sci U S A. 2012; 110(1):282-7. PMC: 3538196. DOI: 10.1073/pnas.1206587110. View

3.
Ruddle N, Akirav E . Secondary lymphoid organs: responding to genetic and environmental cues in ontogeny and the immune response. J Immunol. 2009; 183(4):2205-12. PMC: 2766168. DOI: 10.4049/jimmunol.0804324. View

4.
Puttur F, Denney L, Gregory L, Vuononvirta J, Oliver R, Entwistle L . Pulmonary environmental cues drive group 2 innate lymphoid cell dynamics in mice and humans. Sci Immunol. 2019; 4(36). PMC: 6744282. DOI: 10.1126/sciimmunol.aav7638. View

5.
Pearson C, Thornton E, McKenzie B, Schaupp A, Huskens N, Griseri T . ILC3 GM-CSF production and mobilisation orchestrate acute intestinal inflammation. Elife. 2016; 5:e10066. PMC: 4733039. DOI: 10.7554/eLife.10066. View